Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus
NCT00372957
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
GW823093 15mg
DRUG:
GW823093 placebo capsule
DRUG:
GW823093 30mg
Sponsor
GlaxoSmithKline